This is a preview. View original post on this site
After 16 years of service at Fortune 100 global pharmaceutical giant Johnson & Johnson (J&J), Dr Peter Fasolo has announced he will be retiring from his role as EVP and CHRO at the end of 2024. J&J has announced Dr Fasolo’s successor, Kristen Mulholland, who has worked at the pharma giant since 2005 and has held numerous HR leadership positions. Mulholland’s current role is Head of Human Resources…